McGuire Annie sold $69K of VCYT
McGuire Annie (EVP, General Counsel) sold 1,400 shares of VERACYTE, INC. (VCYT) at $49.31 on 2026-06-04 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides transparency on insider activity but does not introduce new company fundamentals or catalysts.
Market read
Traders may monitor for follow-on insider activity, but this specific filing is unlikely to drive a major repricing by itself.
What to watch
The sale size ($69k) is small relative to typical institutional float; without additional insider activity context, the signal-to-noise is low.
Background
SEC Form 4 reports insider transactions; this one is an open-market sale by an EVP/General Counsel under a pre-arranged Rule 10b5-1 plan.
Ticker impact
Veracyte disclosed an officer (EVP, General Counsel) open-market sale of 1,400 shares on a Rule 10b5-1 plan.
Low likelihood of a sustained price move from this single Form 4; any impact is likely limited to short-term sentiment.
The filing is an ownership-change disclosure (not earnings/M&A/regulatory/drug data) and explicitly states a pre-arranged 10b5-1 plan, which reduces interpretive value.
Market effects
Minimal; this is company-specific insider transaction with no stated operational or clinical linkage.
None.
None.
Counterpoint
Because it’s an officer sale (not a passive fund), some traders may still treat it as a mild negative sentiment input despite the 10b5-1 framing.
Key entities
- issuerVeracyte, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderMcGuire Annie
EVP, General Counsel who sold 1,400 shares at $49.3061 on June 4 under a 10b5-1 plan.